1 |
Wang Y, Ma J, Jiang Y. Transcription factor Nrf2 as a potential therapeutic target for COVID-19. Cell Stress Chaperones 2023;28:11-20. [PMID: 36417098 DOI: 10.1007/s12192-022-01296-8] [Reference Citation Analysis]
|
2 |
Demongeot J, Fougère C. mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation. Vaccines (Basel) 2022;11. [PMID: 36679885 DOI: 10.3390/vaccines11010040] [Reference Citation Analysis]
|
3 |
Ousaka D, Nishibori M. Is hemolysis a novel therapeutic target in COVID-19? Front Immunol 2022;13:956671. [DOI: 10.3389/fimmu.2022.956671] [Reference Citation Analysis]
|
4 |
Wang M, Yu B, Wang J, Wang Y, Liang L. Exploring the role of Xingren on COVID ‐19 based on network pharmacology and molecular docking. Journal of Food Biochemistry. [DOI: 10.1111/jfbc.14363] [Reference Citation Analysis]
|
5 |
Naidu SA, Clemens RA, Naidu AS. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control. Journal of Dietary Supplements. [DOI: 10.1080/19390211.2022.2075072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis. F1000Res 2022;11:102. [DOI: 10.12688/f1000research.108667.1] [Reference Citation Analysis]
|